MedPath

Efficacy and safety of low dose mycophenolate mofetile for remission maintenance in ANCA-associated vasculitis

Phase 3
Recruiting
Conditions
ANCA associated vasculitis
Registration Number
JPRN-UMIN000005242
Lead Sponsor
Department of Medicine, Kidney Center, Tokyo Women's Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

WBC<3000/mm3 pregnant women combine with other immunosuppressant within 4 weeks

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
relapse rate
Secondary Outcome Measures
NameTimeMethod
1,side effect of steroid 2,safety of MMF 3,VDI, SF36, QO
© Copyright 2025. All Rights Reserved by MedPath